SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The award recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The company said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. These metrics underscore the system's expanding clinical utilization and the company's growing footprint in the global surgical robotics market.
The award is significant because it validates SS Innovations' strategy of making robotic surgery more affordable and accessible. By achieving regulatory approvals in multiple countries and demonstrating robust procedure volumes, the company is positioning itself as a viable competitor to established players. The SSi Mantra's capabilities in telesurgery and pediatric procedures also highlight its versatility and potential to address underserved areas in surgical care.
For more details on the award, visit the full press release at https://ibn.fm/XWdRe.
About SS Innovations: The company develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, supporting a variety of procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its solutions. More information is available at ssinnovations.com.
This recognition comes at a time when the surgical robotics industry is experiencing rapid growth, with increasing demand for minimally invasive procedures. SS Innovations' focus on cost efficiency and training could help democratize access to robotic surgery, particularly in emerging markets. The company's forward-looking statements, including those regarding expansion and adoption, are subject to risks and uncertainties as detailed in its SEC filings. See full terms and disclaimers at http://IBN.fm/Disclaimer.
